MART-1(91-110)

MART-1(91-110) is a synthetic peptide fragment derived from the melanoma antigen recognized by T cells-1 (MART-1), an important melanocyte differentiation antigen implicated in melanoma research. Comprising amino acid residues 91 to 110 of the full MART-1 protein, this peptide is widely utilized in immunological studies due to its well-characterized epitope properties and its relevance in T-cell recognition. Its defined sequence and immunogenic features make it a valuable tool for investigating antigen processing, presentation, and cellular immune responses in various experimental settings. As a research-use peptide, MART-1(91-110) supports a range of scientific inquiries into tumor immunology, antigen-specific T-cell activation, and the molecular mechanisms underlying immune surveillance in melanoma.

Epitope Mapping: MART-1(91-110) serves as a critical reagent for mapping T-cell epitopes associated with melanoma antigens. By enabling researchers to delineate the specific regions of the MART-1 protein that are recognized by cytotoxic T lymphocytes, the peptide aids in characterizing the immunodominant sequences involved in anti-tumor immunity. This application is vital for understanding the molecular basis of antigen recognition and for refining the identification of peptide-MHC complexes relevant to immune monitoring.

Antigen Presentation Studies: The peptide is frequently employed to investigate the processing and presentation of melanoma-associated antigens by major histocompatibility complex (MHC) molecules. In vitro assays utilizing MART-1(91-110) allow for controlled analysis of peptide loading onto MHC class I or II molecules, facilitating the study of antigen presentation pathways, peptide binding affinities, and the stability of peptide-MHC complexes. These insights are essential for elucidating how tumor antigens are displayed to the immune system and for optimizing antigen delivery strategies in experimental models.

T-Cell Activation Assays: Researchers utilize MART-1(91-110) in functional assays to stimulate antigen-specific T-cell responses. By pulsing antigen-presenting cells with this defined peptide fragment, it becomes possible to selectively activate and expand MART-1-reactive T-cell populations from peripheral blood or tissue samples. This approach is instrumental in dissecting T-cell receptor specificity, measuring cytokine secretion, and evaluating cytolytic activity, all of which contribute to a deeper understanding of adaptive immune mechanisms in the context of melanoma.

Vaccine Development Research: The defined immunogenicity of MART-1(91-110) makes it a valuable component in preclinical studies focused on peptide-based vaccine design. Scientists employ the peptide to assess its potential to elicit robust cellular immune responses in vitro and in animal models, thereby informing the selection and optimization of candidate vaccine formulations targeting melanoma antigens. Its use in this context supports the rational development of antigen-specific immunization strategies and the evaluation of novel adjuvant systems.

Quality Control and Analytical Validation: Due to its well-characterized sequence and immunological relevance, MART-1(91-110) is also utilized as a reference standard or positive control in analytical assays. Laboratories incorporate the peptide into assay development protocols for validation of peptide synthesis, quantification of peptide-MHC binding, or calibration of T-cell functional assays. Its inclusion in quality control workflows ensures experimental consistency, assay reproducibility, and the reliability of immunological measurements in research applications.

1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

3. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features